Atropos Health, a leader in transforming real-world clinical data into personalized real-world evidence (RWE), has announced the addition of two key executives to its leadership team: Sylvia Isler as Chief Technology Officer and Drew Turitz as Chief Financial Officer. The appointments mark a significant step in the company’s mission to scale high-quality evidence utilization across the healthcare ecosystem, including telehealth, payers, and technology-driven health platforms. Sylvia Isler brings over two decades of experience leading engineering, IT, and architecture teams in scientific computing, enterprise software, cloud infrastructure, and healthtech. She has successfully built and scaled technology organizations at Google, Better Life Partners, and Cityblock Health. Isler holds a Ph.D. in Computer Science from the University of Massachusetts Lowell, with graduate studies at the University of Pennsylvania and undergraduate work at Hampton University. Drew Turitz is a seasoned finance executive with more than 20 years of experience in the healthcare sector. His career spans leadership roles at public and private companies, investment advisory, and entrepreneurship. Most recently, he served as CFO of Fuze Health, a consolidator of pharmacy and lab services. Prior to that, he spent a decade at Teladoc Health, where he led corporate development and strategic partnerships, and was part of the founding team at Sandbox / Blue Venture Fund. He also held leadership positions at Aetna and worked in healthcare mergers and acquisitions at Bank of America. Turitz earned an MBA from the Kellogg School of Management at Northwestern University. “Atropos Health has built a foundation of quality, trust, and methodologically sound approaches to closing the evidence gap in medicine,” said Dr. Nigam Shah, Professor of Medicine at Stanford University, Chief Data Scientist at Stanford Health Care, and Co-Founder of Atropos Health. “The combined expertise of Sylvia and Drew will ensure our pace of innovation accelerates into the everyday practice of medicine.” Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health, highlighted the strategic importance of the hires. “As evidence becomes a key transactional unit in care decisions and value determination, Atropos is uniquely positioned to support this growing demand,” he said. “These leaders bring the experience and vision needed to scale our impact across the healthcare ecosystem.” This announcement follows the recent appointment of Kevin Smith as Chief Growth Officer, further strengthening Atropos Health’s leadership team as it expands its reach and capabilities. Atropos Health develops GENEVA OS®, the operating system for rapid healthcare evidence across a network of real-world data. The platform enables healthcare and life science organizations to close evidence gaps from research to patient care, improve individual outcomes through data-driven decisions, and accelerate medical research. The company is dedicated to transforming healthcare by delivering timely, relevant, real-world evidence at scale. For more information, visit www.atroposhealth.com or follow the company on LinkedIn and X (formerly Twitter).